Showing results (171-180 of 265) with videos related to

Sort By:
Pageof 27
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022Ryan Sandford, Ruchi Yadav, Emma K Noble, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and CefepimeBhagyashri Navalkele, Jason M Pogue, Shigehiko Karino, et al.
American Journal of Preventive Medicine|September 13, 2025
Does Home COVID-19 Testing Bias COVID-19 Vaccine Effectiveness Estimates?Mary Patricia Nowalk, G K Balasubramani, Helen D'Agostino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2020
Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017Manjusha Gaglani, Anupama Vasudevan, Chandni Raiyani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2020
Reducing Antibiotic Use in Ambulatory Care Through Influenza VaccinationEmily R Smith, Alicia M Fry, Lauri A Hicks, et al.
MMWR. Morbidity and Mortality Weekly Report|February 16, 2018
Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018Brendan Flannery, Jessie R Chung, Edward A Belongia, et al.
American Journal of Infection Control|December 4, 2012
Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control studyKayoko Hayakawa, Dror Marchaim, Jason M Pogue, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2017
Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017Brendan Flannery, Jessie R Chung, Swathi N Thaker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2025
Absolute and Relative Effectiveness of Cell- and Egg-based Quadrivalent Inactivated Influenza Vaccine Products from 2014-2015 to 2018-2019 seasons, U.S. Flu VE NetworkManjusha Gaglani, Chandni Raiyani, Kempapura Murthy, et al.
American Journal of Infection Control|February 14, 2012
"Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosaDror Marchaim, Federico Perez, Jiha Lee, et al.
Pageof 27